XML 25 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity, Equity Incentive Plans And Warrants
12 Months Ended
Dec. 31, 2011
Stockholders' Equity, Equity Incentive Plans And Warrants [Abstract]  
Stockholders' Equity, Equity Incentive Plans And Warrants

11. Stockholders' Equity, Equity Incentive Plans and Warrants

Stock Incentive Plans

2009 EIP. Our stockholders approved the 2009 Equity Incentive Plan, or the 2009 EIP, at our Annual Meeting of Stockholders held on June 15, 2009. The 2009 EIP authorizes the issuance or grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance awards, performance cash awards and other stock awards to our employees, directors and consultants and is intended as the successor to and continuation of our 2000 EIP. Following the approval of the 2009 EIP by our stockholders, no additional stock awards may be granted under the 2000 Amended and Restated Equity Incentive Plan, or the 2000 EIP. All outstanding stock awards granted under the 2000 EIP will remain subject to the terms of the 2000 EIP provided, however, that any shares subject to outstanding stock awards granted under the 2000 EIP that expire or terminate for any reason prior to exercise or settlement shall become available for issuance pursuant to awards granted under the 2009 EIP. Awards granted under the 2000 EIP expire 10 years from the date of grant. Awards granted under the 2009 EIP expire seven years from the date of grant. As of June 15, 2009, the total number of shares of our common stock reserved for issuance under the 2009 EIP consisted of 4,500,000 shares plus 7,112,217 shares that are subject to outstanding stock awards under the 2000 EIP that may become available for grant under the 2009 EIP if they expire or terminate for any reason prior to exercise or settlement under the 2000 EIP. On May 2, 2011 shareholders approved our Amended 2009 Equity Incentive Plan, primarily to increase the share reserve by 8,000,000 shares. Unless sooner terminated by our Board of Directors, the 2009 EIP shall automatically terminate on April 26, 2019, the day before the tenth anniversary of the date the 2009 EIP was adopted by the Board. The Board of Directors may also amend the 2009 EIP at any time subject to applicable laws and regulations, including the rules and regulations of The NASDAQ Stock Market LLC. In general, no amendment or termination of the 2009 EIP may adversely affect any rights under awards already granted to a participant unless agreed to by the affected participant.

During 2010 and 2011, we granted restricted stock and options to purchase common stock with various vesting as approved by the Board upon each grant. As of December 31, 2011, 2,027,414 shares of restricted stock were outstanding under the 2009 EIP, of which 438,313 were performance-based restricted stock awards. These performance–based awards consist of 131,334 shares that were issued in January 2010, 28% of which will vest in the first quarter of 2012 provided that the time-based objectives are achieved, and 306,979 shares granted in 2011, that will vest in 2012 and 2013 provided that the performance objectives are achieved. We will determine the actual number of shares the recipient receives based on results achieved versus goals based on internal non-financial operational targets. Additionally, 194,124 shares of restricted stock were outstanding under the 2000 EIP. As of December 31, 2011, options to purchase 2,600,742 and 4,253,297 shares of common stock were outstanding under the 2009 EIP and 2000 EIP, respectively. 6,931,498 shares of common stock remained available for grant under the 2009 EIP.

2000 NEDSOP. Under our 2000 Non-Employee Directors Stock Option Plan, or 2000 NEDSOP, nonqualified stock options to purchase common stock are automatically granted to our non-employee directors upon appointment to our Board of Directors (initial grants) and upon each of our annual meeting of stockholders (annual grants). Options granted under the 2000 NEDSOP expire 10 years from the date of the grant. Initial grants vest over four years, with 25% of the shares subject to the option vesting one year from the date of grant and the remaining shares subject to the option vesting ratably thereafter on a monthly basis. Annual grants are fully vested on the date of grant. 1,000,000 shares of common stock are reserved for issuance under the 2000 NEDSOP. As of December 31, 2011, options to purchase 460,000 shares of common stock were outstanding under the 2000 NEDSOP and options to purchase 433,124 shares of common stock remained available for grant under the 2000 NEDSOP.

2000 ESPP. Our stockholders approved our Amended and Restated Employee Stock Purchase Plan, or 2000 ESPP, at our Annual Meeting of Stockholders held on June 15, 2009, primarily to increase the share reserve under the 2000 ESPP by 4,000,000 shares. The 2000 ESPP qualifies under the provisions of Section 423 of the Internal Revenue Code, or IRC, and provides our eligible employees, as defined in the 2000 ESPP, with an opportunity to purchase shares of our common stock at 85% of fair market value. There were 895,071 and 667,265 shares issued under the 2000 ESPP for the years ended December 31, 2010 and 2011, respectively. As of December 31, 2011, the 2000 ESPP had a total of 2,542,630 shares available for purchase.

As of December 31, 2011, total unrecognized share-based compensation cost related to unvested stock options, restricted stock awards, management stock incentive plan and our 2000 ESPP was $5.5 million, which is expected to be recognized over a weighted-average period of approximately 2.9 years. The following table summarizes share-based compensation expense for the years ended December 31, (in thousands):

 

     2009      2010      2011  

Cost of goods sold

   $ 382       $ 489         828   

Sales and marketing

     288         333         540   

Research and development

     1,112         1,231         2,382   

General and administrative

     1,040         950         1,635   
  

 

 

    

 

 

    

 

 

 

Share-based compensation expense before taxes

     2,822         3,003         5,385   

Related deferred income tax benefits

     —           —           —     
  

 

 

    

 

 

    

 

 

 

Share-based compensation expense

   $ 2,822       $ 3,003       $ 5,385   

Share-based compensation expense is derived from:

        

Stock options

   $ 2,237       $ 1,589         1,478   

Restricted stock awards

     310         1,052         2,482   

Stock bonus plan

     —           —           1,006   

2000 ESPP

     275         362         419   
  

 

 

    

 

 

    

 

 

 

Total

   $ 2,822       $ 3,003       $ 5,385   
  

 

 

    

 

 

    

 

 

 

We estimate forfeitures at the time of grant and revise, if necessary, in subsequent periods if actual forfeitures differ from those estimates. We have historically and continue to estimate the fair value of share-based awards using the Black-Scholes option-pricing model.

A summary of stock option activity is as follows:

 

      Number of
shares
    Weighted
average
exercise price
     Weighted average
remaining
contractual term
(in years)
     Aggregate
intrinsic value
 

Outstanding at January 1, 2011

     6,179,547      $ 3.57         

Granted

     1,902,500        2.58         

Exercised

     (291,984 )     1.90         

Forfeited

     (204,919 )     2.12         

Expired

     (190,593     4.83         
  

 

 

   

 

 

       

Outstanding at December 31, 2011

     7,394,551      $ 3.39         5.17       $ 81,196   

Vested and expected to vest at December 31, 2011

     7,076,011      $ 3.43         5.08       $ 80,547   

Exercisable at December 31, 2011

     4,877,883      $ 3.96         4.82       $ 55,672   

A summary of restricted stock award activity for 2011 is as follows:

 

     Number of
shares
    Weighted
average grant
date fair value
 

Outstanding at January 1, 2011

     2,099,523      $ 1.47   

Granted

     1,362,329        2.68   

Vested

     (825,760     1.67   

Forfeited

     (402,529     1.73   
  

 

 

   

 

 

 

Outstanding and unvested at December 31, 2011

     2,233,563      $ 2.09   
  

 

 

   

 

 

 

 

The weighted average grant-date fair values of options granted during the years ended December 31, 2009, 2010 and 2011 were $0.45 per share, $0.97 per share, and $1.78 per share, respectively. The total intrinsic value of options exercised during the years ended December 31, 2009, 2010 and 2011 were $0.0 million, $0.0 million, and $0.8 million, respectively.

The weighted average grant-date fair values of restricted stock awards granted during the years ended December 31, 2009, 2010 and 2011 were $0.55, $1.68 and $2.68 per share, respectively. The fair value of restricted stock awards that vested during the years ended December 31, 2009, 2010 and 2011 was $0.1, $0.8 and $1.4, respectively.

Cash generated from options exercised under all share-based compensation arrangements for the years ended December 31, 2009, 2010 and 2011 were $0.0 million, $0.1 million and $0.5 million, respectively. Cash generated from the purchase of shares through the 2000 ESPP for the years ended December 31, 2009, 2010 and 2011, was $0.5 million, $0.7 million, and $0.9 million respectively. We issue new shares from the respective plan share reserves upon exercise of options to purchase common stock and for purchases through the 2000 ESPP.

The aggregate intrinsic value in the stock option summary table above is based on our closing stock price of $1.33 per share as of the last business day of the fiscal year ended December 31, 2011, which value would have been realized by the optionees had all options been exercised on that date. The total fair value of options to purchase common stock that vested during the years ended December 31, 2009, 2010 and 2011 was $2.4 million, $1.1 million, and $1.2 million, respectively.

To estimate compensation expense for the years ended December 31, 2009, 2010, and 2011 we used the Black-Scholes option-pricing model with the following weighted-average assumptions for equity awards granted:

 

     EIP and NEDSOP     ESPP  
     Years Ended
December 31,
    Years Ended
December 31,
 
     2009     2010     2011     2009     2010     2011  

Risk-free interest rate

     2.01 %     2.25 %     1.84 %     0.32 %     0.19 %     0.17 %

Expected dividend yield

     0.00 %     0.00 %     0.00 %     0.00 %     0.00 %     0.00 %

Volatility

     69 %     74 %     85 %     120 %     101 %     70 %

Expected Term

     5.5 years        5.9 years        5.36 years        0.5 years        0.5 years        0.5 years   

Forfeiture Rate

     0%-12.37 %     0%-12.69%       0%-12.25 %     0 %     0 %     0 %

The risk-free interest rate is based on the implied yield available on United States Treasury issues with an equivalent remaining term. We have not paid dividends in the past and do not plan to pay any dividends in the future.

The expected volatility is based on historical volatility of our stock for the related vesting period. The expected life of the equity award is based on historical experience.

The forfeiture rate is estimated when awards are granted and updated if information becomes available indicating that actual forfeitures will differ.

Warrants

In January 2008, we amended our Product Purchase Agreement, or Agreement, originally entered into with HP in September 2007, to allow for sales to additional divisions within HP. In connection with the Agreement, we issued a warrant to HP to purchase 1,602,489 shares of our common stock (approximately 3.5% of our outstanding shares prior to the issuance of the warrant) at an exercise price of $2.40 per share.

On October 31, 2011, we amended again the Product Purchase Agreement originally entered into with HP on September 10, 2007. In part, this Amendment extends until October 30, 2016 the expiration date of the warrant previously issued to HP to purchase 1,602,489 shares of our common stock at the original exercise price of $2.40 per share. The impact of this extension on our financial statements is a non-cash contra-revenue charge of approximately $1.0 million in Dot Hill's 2011 statement of operations.